Drugs / dl-Leucovorin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02923921 Background | Mar 2017 → Sep 2019 | malignant pancreatic neoplasm | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dl-Leucovorin | “dl-Leucovorin (dl-LV) 400 milligram per meter square (mg/m2) and oxaliplatin 85 mg/m2 followed by bolus 5-fluorouracil (5-FU) 400 mg/m2” NCT02923921 ↗ |
| Known as | dl-LV | “dl-Leucovorin (dl-LV) 400 milligram per meter square (mg/m2)” NCT02923921 ↗ |